Avinger (NASDAQ:AVGR) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR) in a research report issued on Tuesday. The firm set a “hold” rating on the medical device company’s stock.

Avinger Trading Down 1.6 %

Shares of Avinger stock opened at $1.23 on Tuesday. The firm’s 50-day moving average price is $1.74 and its 200 day moving average price is $2.76. Avinger has a twelve month low of $1.11 and a twelve month high of $14.00. The firm has a market capitalization of $2.09 million, a PE ratio of -0.07 and a beta of 1.26.

Avinger (NASDAQ:AVGR) last announced its quarterly earnings data on Wednesday, May 15th. The medical device company reported ($2.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.35) by ($1.14). The company had revenue of $1.86 million for the quarter, compared to the consensus estimate of $2.36 million. On average, sell-side analysts predict that Avinger will post -2.08 EPS for the current fiscal year.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.